Molecular Determinants of Cancer Therapeutic Response
Description: OVERALL – Narrative Adult acute myelogenous leukemia (AML) and glioblastoma multiforme (GBM) are therapeutically challenging, lethal human malignancies. Our goal is to develop better ways to treat both of these devastating diseases by identifying, and then exploiting, tumor-specific vulnerabilities to improve treatment and outcomes.
Funder: National Cancer Institute
Funding type: program
Funder scheme: P01
Start date: 1999-05-14
End date: 2021-06-30
Investigator: RAYMOND J MONNAT
Institution: UNIVERSITY OF WASHINGTON
Funded outputs count: 191
Funder award ID: P01CA077852
OpenAlex ID: G691838600